Suppr超能文献

原发性醛固酮增多症的侧别定位程序

Lateralization procedures in primary aldosteronism.

作者信息

Vetter H, Brecht G, Fischer M, Galanski M, Glänzer K, Cramer B M, Pouliadis G, Sialer G, Studer A, Tenschert W, Wollnik S, Zumkley H, Vetter W

出版信息

Klin Wochenschr. 1980 Oct 15;58(20):1135-41. doi: 10.1007/BF01477235.

Abstract

The diagnostic validity of adrenal isotopic scanning, adrenal venous aldosterone, adrenal phlebography and computed abdominal tomography (CT) was studied in 44 patients with primary aldosteronism. In all patients the diagnosis was confirmed by surgery (unilateral adrenal adenoma n = 32, bilateral adrenal hyperplasia n = 12). Both adrenal scintiscan, adrenal venous aldosterone and CT allowed in a comparable high percentage of patients (71%0 the exact classification of the adrenal lesion(s), whereas adrenal phlebography could distinguish adenoma from hyperplasia in 57%. Marked differences between the lateralization procedures, however, were observed in predicting incorrect preoperative indentification: adrenal scintiscan 29%, adrenal venous aldosterone 3%, adrenal veno-graphy 6% and CT 0%. Finally, the percentage of patients in whom no differentiation between the two main subgroups of primary aldosteronism could be obtain varied between 0% with adrenal isotopic scanning and 37% with adrenal phlebography (CT 29% and adrenal venous aldosterone 26%). Both scintiscan and adrenal venous aldosterone were not improved by the administration of dexamethasone. Our findings document that adrenal venous aldosterone determinations, adrenal isotopic scanning and computed tomography are equally valid in differentiating unilateral adenoma from bilateral adrenal hyperplasia in primary aldosteronism. However, adrenal scintiscan is hampered by a relative high percentage of incorrect results independant whether dexamethasone was used or not. Contrary, adrenal venous aldosterone and computed tomography seemed to have no or only a minor risk in assuming an incorrect classification of the adrenal lesion(s).

摘要

对44例原发性醛固酮增多症患者进行了肾上腺同位素扫描、肾上腺静脉醛固酮测定、肾上腺静脉造影和腹部计算机断层扫描(CT)的诊断有效性研究。所有患者均经手术确诊(单侧肾上腺腺瘤n = 32,双侧肾上腺增生n = 12)。肾上腺闪烁扫描、肾上腺静脉醛固酮测定和CT在相当高比例的患者中(71%)能准确区分肾上腺病变,而肾上腺静脉造影能在57%的患者中区分腺瘤与增生。然而,在预测术前错误诊断方面,不同定位方法存在显著差异:肾上腺闪烁扫描为29%,肾上腺静脉醛固酮测定为3%,肾上腺静脉造影为6%,CT为0%。最后,在原发性醛固酮增多症的两个主要亚组之间无法区分的患者比例,肾上腺同位素扫描为0%,肾上腺静脉造影为37%(CT为29%,肾上腺静脉醛固酮测定为26%)。给予地塞米松后,闪烁扫描和肾上腺静脉醛固酮测定均无改善。我们的研究结果表明,在原发性醛固酮增多症中,肾上腺静脉醛固酮测定、肾上腺同位素扫描和计算机断层扫描在区分单侧腺瘤与双侧肾上腺增生方面同样有效。然而,无论是否使用地塞米松,肾上腺闪烁扫描都因相对较高比例的错误结果而受到影响。相反,肾上腺静脉醛固酮测定和计算机断层扫描在对肾上腺病变进行错误分类方面似乎没有风险或只有很小的风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验